23
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Comparison of urinary excretion of albumin and alpha-1-antitrypsin in patients with arterial hypertension

, , &
Pages 93-97 | Published online: 08 Jul 2009

REFERENCES

  • Ritz E, Nowicki M, Fliser D, Homer D, Klimm HP. Proteinuria and hypertension. Kidney Int 1994; 46 (Suppl 47): S76–80.
  • Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Hypertension 1993; 21: 810–5.
  • Hall WD. Renal issues in the management of hypertension. Am J Hypertens 1993; 6: S245–50.
  • Ljungman S. Microalbuminuria in essential hyper-tension. Am J Hypertens 1990; 3: 956–60.
  • Rambausek M, Fliser D, Ritz E. Albuminuria of hypertensive patients. Clin Nephrol 1992; 38 (Suppl 1): S40–5.
  • Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjects. J Diabetes Complications 1994; 8: 180–8.
  • Biesenbach G, Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihyper-tensive therapy. Clin Nephrol 1994; 41: 211–8.
  • Bigazzi R, Bianchi S, Campese V, Baldari G. Prevalence of microalbuminuria in large popula-tion of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94–7.
  • Mimran A, Ribstein J, DuCailar G, Halimi JM. Albuminuria in normals and essential hyperten-sion. J Diabetes Complications 1994; 8: 150–6.
  • Mimran A, Ribstein J, DuCailar. Is microalbumi-nuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hyperten-sion 1994; 23: 1018–21.
  • Danishefsky SJ. Biochemistry for medical sciences. Boston: Little, Brown & Co., 1980
  • Boomsma DI, Orbeleke JF, Martin NG, Frants RR, Clark P. Alpha-l-antitrypsin and blood pressure. Lancet 1991; 337: 1547.
  • Huggard PR, West MJ, Summers KM. a-1-antitrypsin deficiency alleles and blood pressure in an Australian population. Clin Exp Pharmacol Physiol 1996; 23: 600–1.
  • Schievink WI, Katzmann JA, Piepgras DG, Schaid DJ. Alpha-l-antitrypsin phenotypes among patients with intracranial aneurysms. J Neurosurg 1996; 84: 781–4.
  • Elzouki ANY, Eriksson S. Abdominal aortic aneurysms and alphai-antitrypsin deficiency. J Intern Med 1994; 236: 587–91.
  • Cohen JR, Sarfati I, Ratner L, Tilson D.-antitrypsin phenotypes in patients with abdominal aortic aneurysms. J Surg Res 1990; 49: 319–21.
  • Jean PS, Hart B, Webster M, Steed D, Adamson J, Powell J, Ferrell R. Alpha-l-antitrypsin defi-ciency in aneurysmal disease. Hum Hered 1996; 46: 92–7.
  • Blank CA, Brantly M. Clinical features and molecular characteristics of a-1-antitrypsin defi-ciency. Ann Allergy 1994; 72: 105–20.
  • Vittinghus E. Preanalytical handling of stored urine samples, and measurement of 132-micro-globulin, orosomucoid, albumin, transferrin and immunoglobulin G in urine by enzyme-linked immunosorbent assays (ELISA). Scand J Clin Lab Invest 1990; 50: 843–9.
  • Tencer J, Thysell H, Andersson K, Grubb A. Long-term stability of albumin, protein HC, immunoglobulin G, lc- and X-chain-immuno-reactivity, orosomucoid and al -antitrypsin in urine stored at —20°C. Scand J Urol Nephrol 1977; 31: 67–71.
  • Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing anti-bodies. Anal Biochem 1966; 15: 45–52.
  • Cottone S, Cerasola G. Microalbuminuria frac-tional clearance and early renal permselectivity changes in essential hypertension. Am J Nephrol 1992; 12: 326–9.
  • Pedrinelli R, Giampietro 0, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–8.
  • Mogensen CE. Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med 1994; 235: 297–316.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.